We are live on ! Find out more
JGC

J. Goldman & Co Portfolio holdings

AUM $3.44B
1-Year Est. Return 33.8%
This Fund
S&P 500
This Quarter Est. Return
+13.46%
1 Year Est. Return
+33.8%
3 Year Est. Return
+89.45%
5 Year Est. Return
+82.14%
10 Year Est. Return
+407.39%
AUM
$3.11B
AUM Growth
+$1.14B
Cap. Flow
+$1.02B
Cap. Flow %
32.76%
Top 10 Hldgs %
26.6%
Holding
625
New
271
Increased
74
Reduced
76
Closed
201

Top Buys

Rank Stock Value
1
HSY icon
Hershey
HSY
+$63.1M
2
JWN
Nordstrom
JWN
+$35M
3
MNDT
Mandiant, Inc. Common Stock
MNDT
+$25.1M
4
TBA
Thoma Bravo Advantage
TBA
+$24.8M
5
KTB icon
Kontoor Brands
KTB
+$18.1M

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$34.3M
2
T icon
AT&T
T
+$31.8M
3
AMZN icon
Amazon
AMZN
+$29.9M
4
CTRN icon
Citi Trends
CTRN
+$24.9M
5
RL icon
Ralph Lauren
RL
+$24.4M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 12.1%
2 Industrials 7.29%
3 Technology 6.93%
4 Communication Services 6.82%
5 Financials 4.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AEVA
426
Aeva Technologies
AEVA
$1.37B
– –
-22,122
Closed -$1.61M
AMD icon
427
CALL
Advanced Micro Devices
AMD
$856B
– –
-52,000
Closed -$4.77M
AMD icon
428
Advanced Micro Devices
AMD
$856B
– –
-77,467
Closed -$7.1M
ANF icon
429
CALL
Abercrombie & Fitch
ANF
$4.87B
– –
-141,400
Closed -$2.88M
ANGI icon
430
Angi Inc
ANGI
$248M
– –
-1,407
Closed -$186K
AOS icon
431
PUT
A.O. Smith
AOS
$8.47B
– –
-121,800
Closed -$6.68M
ARKG icon
432
ARK Genomic Revolution ETF
ARKG
$1.63B
– –
-2,415
Closed -$225K
ARKOW
433
CALL
DELISTED
ARKO Corp Warrant
ARKOW
– –
-100,000
Closed -$138K
ASTS icon
434
AST SpaceMobile
ASTS
$20.8B
– –
-30,000
Closed -$407K
AVDL
435
DELISTED
Avadel Pharmaceuticals
AVDL
– –
-233,747
Closed -$1.56M
AYI icon
436
Acuity Brands
AYI
$10.3B
– –
-77,466
Closed -$9.38M
BIIB icon
437
CALL
Biogen
BIIB
$30.6B
– –
-36,000
Closed -$8.81M
BIIB icon
438
Biogen
BIIB
$30.6B
– –
-3,657
Closed -$895K
BLMN icon
439
CALL
Bloomin' Brands
BLMN
$765M
– –
-41,700
Closed -$810K
BMRN icon
440
BioMarin Pharmaceuticals
BMRN
$11.7B
– –
-5,811
Closed -$510K
BMRN icon
441
PUT
BioMarin Pharmaceuticals
BMRN
$11.7B
– –
-84,000
Closed -$7.37M
BTAI icon
442
BioXcel Therapeutics
BTAI
$27.3M
– –
-1,581
Closed -$1.17M
BYND icon
443
PUT
Beyond Meat
BYND
$329M
– –
-3,500
Closed -$438K
CAT icon
444
Caterpillar
CAT
$407B
– –
-1,183
Closed -$215K
CCRN
445
DELISTED
Cross Country Healthcare
CCRN
– –
-147,455
Closed -$1.31M
CELU icon
446
CALL
Celularity
CELU
$21.9M
– –
-10,000
Closed -$275K
CELU icon
447
Celularity
CELU
$21.9M
– –
-18,000
Closed -$1.98M
CHRW icon
448
C.H. Robinson
CHRW
$17.9B
– –
-47,275
Closed -$4.44M
CLX icon
449
Clorox
CLX
$12.4B
– –
-1,009
Closed -$204K
CNK icon
450
PUT
Cinemark Holdings
CNK
$4.37B
– –
-24,000
Closed -$418K
16 17
18
19 20

Similar funds

CIA
Caledonia Investments (Australia) Sydney NSW, Australia $3.44B AUM 20.03% 1-Year Est. Return
PWP
Perfromance Wealth Partners Hinsdale, Illinois $3.45B AUM 29.14% 1-Year Est. Return
RBA
Richard Bernstein Advisors New York $3.45B AUM 16.24% 1-Year Est. Return
PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return
LNC
Lincoln National Corp Radnor, Pennsylvania $3.45B AUM 12.55% 1-Year Est. Return
DAM
Davis Asset Management Sausalito, California $3.46B AUM 9.77% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return
MSC
MUFG Securities (Canada) New York $3.48B AUM 45.13% 1-Year Est. Return

J. Goldman & Co's Q1 2021 Portfolio in Review

As of Q1 2021, J. Goldman & Co held 625 positions worth $3.11B, up 58% from $1.97B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

J. Goldman & Co deployed $1.02B of net new capital in Q1 2021, opening 271 new positions and adding to 74 existing holdings. Its largest new stake was Mandiant, Inc. Common Stock: 1,201,965 shares worth $23.5M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 12% of assets, down from 14% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $34.3M trimmed.

  • J. Goldman & Co's largest Q1 2021 buy was Mandiant, Inc. Common Stock: 1,201,965 shares worth $23.5M.
  • J. Goldman & Co added most to Hershey in Q1 2021, an estimated $63.1M increase.
  • J. Goldman & Co's biggest Q1 2021 reduction was Alphabet (Google) Class A, cutting an estimated $34.3M.
  • J. Goldman & Co fully exited AT&T in Q1 2021, selling an estimated $31.8M.
  • J. Goldman & Co's ten largest holdings make up 27% of its $3.11B portfolio in Q1 2021.
  • J. Goldman & Co opened 271 new positions and closed 201 in Q1 2021.
  • J. Goldman & Co's portfolio value rose 58% quarter-over-quarter to $3.11B.

Based on J. Goldman & Co's 13F filing for Q1 2021, filed 17 May 2021.